resveratrol has been researched along with salinomycin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Mishra, S; Rai, G; Shukla, Y; Suman, S | 1 |
Azad, N; Iyer, AKV; Kaushik, V; Venkatadri, R | 1 |
Dewangan, J; Rath, SK; Srivastava, S; Tandon, D; Verma, AK; Yapuri, A | 1 |
4 other study(ies) available for resveratrol and salinomycin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Evaluation of growth inhibitory response of Resveratrol and Salinomycin combinations against triple negative breast cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cadherins; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Humans; Mice; NF-kappa B; Pyrans; Resveratrol; Stilbenes; Triple Negative Breast Neoplasms | 2017 |
A novel resveratrol-salinomycin combination sensitizes ER-positive breast cancer cells to apoptosis.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Humans; Pyrans; Receptors, Estrogen; Resveratrol; Signal Transduction; Stilbenes; Wnt Proteins | 2017 |
Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Flow Cytometry; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; MCF-7 Cells; Pyrans; Reactive Oxygen Species; Resveratrol; Stilbenes; Tumor Stem Cell Assay | 2017 |